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Abstract 
The  relevance  of  physiological  immune  aging  is  of  great  interest  with  respect  to determining  disorders with 
pathologic immune function in aging individuals. In recent years, the relevance of changes in peripheral lymphocytes 
in age-associated  neurologic diseases has become more evident.  Due to the lack of immunological studies. covering 
moce than one event after mitogenic activation, we envisaged a new concept in the present study, aiming to investigate 
several events, starting from T cell  receptor (TCR) ligation  up to T cell  proliferation. In addition, we  addressed the 
question whether changes are present in  the subsets (CD4, CDR)  with  aging. Phosphorylation  of tyrosine  residues 
declines with increasing age in CD4+ cells. Fewer levels of CD69 positive cells after 4 h mitogenic activation, altered 
expression  of  cytokines  (IL2, IFN-7  and  TNF-a;  22  h) and lower  proliferation  (72 h) were detemined in  aging. 
Moreover, it could be  shown that CD8"  lymphocytes react more effectively to mitogenic stirnulation with referenoe 
to CD69 expression and proliferation in both age groups ( < 35 and >  60 years old). These data indicate that T  cell 
activation, rnediated by TCR engagement, is significantly impaired in aging and both subsets are affected. However, 
bypassing the TCR does not fully restore T cell function, indicating that there are more mechanisms involved than 
impaired  signal  transduction  thwugh  TCR  only.  The  results will  be  discussed  in  relation  to iiheir  relevance  in 
neurodegenerative and psychiatric disorders. 
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1. Introduction
Gerontology, especially immunogerontology, is
becoming an increasingly important discipline in
medicine, since more people are aging in the
industrialized countries. A decline of immune
function, termed immunosenescence, has been
known for decades, mainly involving speciﬁci m -
munity (Guidi et al., 1998; Pawelec et al., 1999;
Castle, 2000; Ginaldi et al., 2001; Linton and
Thoman, 2001). However, the causes for im-
munosenescence remain unclear. Membrane
changes taking place in the aging process are
involved in altered binding of hormones, antigens
and cytokines (Woda et al., 1979), as well as in
defective transmission through ion channels
(Grifﬁth et al., 2000). Moreover, other theories
explain declined cellular activity within aging by
increased oxidative stress (Guyton et al., 1998).
Previous studies on lymphocytes revealed an in-
crease of reactive oxygen species (ROS) in aged
subjects (Schindowski et al., 2000) or elevated
by-products caused by ROS (e.g. lipidperoxida-
tion (Hendricks and Heidrick, 1998), oxidized
proteins (Stadtman, 1992; Berlett and Stadtman,
1997) and DNA-damage (Wei et al., 1998)). Al-
tered and impaired signal transduction, in general,
seems to be a major cause for impaired cellular
function in all aged tissues (Eckert et al., 1994;
Mu ¨ller et al., 1996).
The performance of the immune system is
closely related to the health situation of the indi-
vidual. Longevity is associated with appropriate
immune function (Sansoni et al., 1992, 1997;
Franceschi et al., 1995). Moreover, recent re-
search indicates that the immune system is not
autonomous. It interacts with the whole organism
in bi-directional ways (Guidi et al., 1998). Close
interaction of the central nervous system (CNS)
and immune cells has become more evident in
recent years. Immune cell function is modulated
by neuroendocrines as well as by neurotransmit-
ters and vice versa (Hanisch et al., 1996; Carson
and Sutcliffe, 1999). In addition, neurodegenera-
tive diseases, such as dementia of Alzheimer type
(DAT (Eckert et al., 1998, 2001; Schindowski et
al., 1999)), Down’s Syndrome (DS (Park et al.,
2000)) and the demyelating disease, multiple scle-
rosis (MS (Crucian et al., 1995a)) are accompa-
nied by altered lymphocyte function and
apoptosis. Chronic psychosocial and emotional
stress is associated with declined and/or impaired
immune function (Berkenbosch et al., 1991).
The clinical relevance of immunosenescence is
quite high, since impaired function of the immune
network contributes to pathologies such as can-
cer, increased susceptibility to infectious diseases
and autoimmune disorders, cardiovascular dis-
eases and the not clearly deﬁned general multi-
morbidity (Bruunsgaard et al., 2000a). Moreover,
a prospective study emphasized the close relation
between decreased T cell proliferation after mito-
genic activation and increased mortality (Mu-
rasko et al., 1987).
The relevance of physiological immune aging is,
in addition, of great interest with respect to deter-
mine disorders with pathologic immune function
in aging individuals. However, there is growing
evidence that neurological disorders are often as-
sociated with changed immune properties. Im-
mune cells provide good accessibility and are
therefore a useful tool to explore the mechanism
taking place within these disorders.
Here, we describe the function of T lymphocyte
subsets (CD4, T helper cells and CD8, cytotoxic T
suppressor cells) in physiological ‘healthy’ aging.
We determined early events as tyrosine phospho-
rylation and CD69 expression and subsequent
events, such as cytokine expression and prolifera-
tion after T cell-receptor engagement or by by-
passing this receptor with phorbol ester (PMA)
and Ca
2+ ionophores (Ionomycin).
This study is of great importance and relevance
to compare immunological changes taking place
in many diseases in elderly patients, for instance,
many neuroinﬂammatory diseases show changes
in peripheral immune competent cells.
2. Material and methods
2.1. Subjects
Blood samples were taken from healthy subjects
35 years, termed young (n=22; 15 women and
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healthy persons 60 years, termed old group
(n=25, 16 women, nine men, mean age 72.99.2
years). The remainders were part of the intermedi-
ate ages shown in Figs. 2 and 3. Subjects with
psychiatric and neurodegenerative disorders or
acute infections were excluded. In addition, sub-
jects with pathological distribution of lymphocyte
subpopulations in ﬂow cytometric analysis ac-
Fig. 2. Lymphocyte subset distribution in aging. The percent-
age of all FSC-SSC-gated lymphocytes was determined and
plotted against donor’s age. (A) The percentage of CD3
positive cells signiﬁcantly decreases with increasing age of the
blood donor. (B) The subset distribution of the CD3+ T cells,
expressed as CD4/CD8-ratio, did not differ signiﬁcantly be-
tween the two age groups. (C) The percentage of natural killer
(NK) lymphocytes signiﬁcantly rises with increasing donor’s
age.
Fig. 1. (A) The total number of CD4 and CD8 lymphocytes is
signiﬁcantly reduced in blood samples from aged donors. Cell
counts were determined by using the TrueCount
® kit, provid-
ing a standardized number of beads in the staining tube. (B)
The density of the costimulatory receptors CD4 and CD8 on
lymphocytes from young and old subjects. Mean ﬂuorescence
intensity (MFI) determined by the mean channel number is
proportional to the density of the measured receptor. No
changes concerning CD4-receptor density were observed be-
tween lymphocytes from young and old donors. In contrast, a
signiﬁcant decrease of CD8-receptors was determined in
lymphocytes from aged donors when compared with young
donors.K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 378
cording to the Senieur protocol (Ligthart et al.,
1984) were rejected from the study. Most of the
elderly patients were taking drugs against cardio-
vascular disorders. None of the patients received
psychotropic medication, drugs with known ef-
fects on the immune system or antioxidative
agents.
This study was approved by the responsible
ethical committee and written informed consent
was obtained from all subjects.
2.2. Whole blood cultures
Blood was collected in NH4-heparin vacuum
syringes. One volume of blood was diluted in 9
volume of RPMI supplemented with penicillin
(100 U/ml) and streptomycin (100 g/ml; all Gib-
coBRL, Karlsruhe, Germany). The cell suspen-
sion was cultured in 96-well plates (Iwaki/Dunn,
Germany). Cells were stimulated with either
PHA-L (10 g/ml) or 12-O-tetradecanoyl 12-
phorbol 13-acetate (PMA) and Ionomycin (50
and 200 ng/ml, respectively; all Sigma, Germany)
or remained untreated (basal).
2.3. Cytometry
Whole blood cultures were transferred into a
1.2 ml 96-well plate, centrifuged at 300×g and
the supernatants were discarded. Whole blood
was stained with the appropriate antibodies (all
were purchased from Pharmingen/Becton Dickin-
son, Heidelberg, Germany) following the manu-
facturer’s manual. In brief, 1 l of each antibody
was added to blood cell pellets and incubated for
10 min at room temperature. Red blood cells were
lysed by adding 500 l of hypotonic buffer (Cell-
Lyse
®, Becton Dickinson) for 15 min. Since
Fig. 3. Phosphorylation of tyrosine residues upon PHA-L activation in aging. Whole blood cultures were stimulated with PHA-L
f o r3m i na t3 7°C and intracellularly stained with an antibody that detects phosphorylated tyrosine residues or an isotype-control.
Data are expressed as ratio of PHA-stimulated and unstimulated cells. The ratio of the mean ﬂuorescence intensities (MFI) of
phosphorylated tyrosines of PHA-L stimulated and untreated cells correlates signiﬁcantly with the donor’s age in CD4
+ cells (open
circles, dashed line). When the groups of young and aged donors were compared, there was a signiﬁcant decrease of phosphorylated
tyrosine residues in the group of old volunteers (inset). In CD8
+ lymphocytes, a tendency towards reduced levels could be observed
with aging, however, those changes are not signiﬁcant.K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 379
PMA/Ionomycin treatment stabilizes the red
blood cell membrane, 1 ml CellLyse was needed to
completely lyse the erythrocytes. Cells were pel-
leted by 300×g and additionally washed with 500
l CellWash
® (Becton Dickinson).
Samples were assayed with FACSCalibur using
Simulset software (all Becton Dickinson). Dead
cells, granulocytes and monocytes were excluded
by forward (FSC) and side (SSC) angle scattered
light gating. For each sample, except total numer-
ation with TrueCount
® beads, 10,000 cells were
acquired. All ﬂuorescence channels were acquired
on a logarithmic scale.
The lymphocyte subsets were quantiﬁed by
staining with anti-CD3-FITC (clone SK7), anti-
CD19-PE (clone 4G7) and anti-CD16-PE (clone
B73.1)+anti-CD56-PE (clone MY31), in order to
explore the percentage of T-, B- and NK-
lymphocytes, respectively. T lymphocyte subsets
were determined by staining with anti-CD4-FITC
(clone SK3) and anti-CD8-PR (clone SK1; all
Becton Dickinson). Early T cell activation was
determined by staining with anti-CD69-FITC
(clone L78) or IgG1-isotype control (clone X40).
In all experiments concerning activation with
PHA-L or PMA/Ionomycin, cells were stained
with CD3-PerCp and CD8-PE in order to gate all
CD3





− lymphocytes. The ﬁnd-
ings of Rostaing et al. (1999) and unpublished
data of our group revealed that the CD4 antigen
is down-regulated after PHA activation, while the
CD8 surface density remains unchanged. There-
fore, we electronically gated the CD3
+CD8
+ cells
(T cytotoxic/suppressor cells) and the CD3
+
CD8
− cells (mostly CD3
+CD4
+ or T helper cells)
and assumed that most CD8
− cells are CD4
+.I n
preliminary experiments, no age-related changes
in the percentage of double positive (CD4
+CD8
+)




2.4. Quantiﬁcation of lymphocyte number
Absolute numbers of lymphocytes were deter-
mined with TrueCount
® beads (Becton Dickinson)
and CD3-PerCp, CD8-PE and CD4-FITC, ac-
cording to the manufacturer’s manual. In brief, 50
l of whole blood and 1 l antibody reagent
containing ﬂuorochrome conjugated antibodies
against anti-CD3, anti-CD8, and anti-CD4
(TriTest
®, Becton Dickinson) were pipetted into a
TrueCount
® tube containing a speciﬁc amount of
beads and incubated for 15 min at room tempera-
ture. Some 250 l CellLyse
® were added for an
additional 15 min, in order to lyse red blood cells.
Samples were measured by ﬂow cytometry with
settings appropriate for suspension containing
lysed red blood cells without wash. For each
sample, 100,000 cells were acquired. Cell popula-
tion and beads were gated and cell count calcu-
lated in relation to the bead’s number.
2.5. Detection of cytokine expressing cells
Whole blood cultures were placed in an incuba-
tor for 22 h at 37 °C. For cytokine detection, cells
were incubated with Brefeldin A (Sigma) at a
concentration of 10 g/ml for the last 16 h of
stimulation, to inhibit cytokine secretion. Cultures
were surface stained as described above, followed
by ﬁxation and permeabilization with FACS-
Perm
® (Becton Dickinson). Intracellular cytokine
staining was performed with anti-cytokine mAbs
speciﬁc for IL2, IFN- and TNF- or an isotype
control (clones 5344.111, 25723.11 or 6401.1111,
respectively; Becton Dickinson) in FACSPerm
®
for 30 min at room temperature.
2.6. Determination of proliferation
Whole blood cultures were incubated for 72 h
with or without stimulation at 37 °C. Before har-
vest (24 h), Brom-3desoxy-uridine (BrdU; Sigma)
was added at a ﬁnal concentration of 20 Mt ot h e
cultures. Cells were stained according to Gaines et
al. (1996) using an anti-BrdU-antibody or isotype
control (Becton Dickinson). In brief, surface re-
ceptors were stained as described above. After red
blood cell lysis and an additional washing-step,
leukocytes were transferred into a 96-microtiter
round-bottom plate and ﬁxed with 100 l4 %
paraformaldehyde (CellFix
®, Pharmingen)
overnight at 4 °C. Cells were permalized by wash-
ing with saponin-containing buffer (PermWash
®).
Cells were resuspended in PBS containing 10 mMK. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 380
MgCl2 (Sigma) and 50 U DNase-I (Boehringer
Mannheim/Roche, Germany) and incubated at
37 °C for 45 min. DNA digest was stopped by
centrifugation at 4 °C, cells were washed and
resuspended in 50 l PermWash
®. Blood cells
were stained with 1 l of an anti-BrdU-antibody
(clone B44) or IgG1-isotype control (Becton Dick-
inson) for 30 min at room temperature in the
dark. After washing out excessive antibodies, cells
were resuspended in CellWash
® and analyzed by
ﬂow cytometry.
2.7. Determination of phosphorylated tyrosine
residues
T cells were stimulated and samples prepared
according to Hubert et al. (1997). In brief, 500 l
diluted whole blood was transferred into micro-
centrifuge tubes and brought to 37 °C in a heat-
block with gentle agitation. Cells were activated
by the addition of PHA-L (10 g/ml) for 3 min,
rapidly chilled on ice and centrifuged at 500×g.
Pellets were resuspended in freezing medium, con-
taining 10% DMSO (Sigma) and 50% FCS in
RPMI medium (GibcoBRL). Samples were stored
at −20 °C until analysis. For sample prepara-
tion, cells were rapidly thawed at 37 °C, trans-
ferred into a 1.2 ml 96-well plate and washed
twice with CellWash
®. Red cell lysis was not
necessary since freezing the cells already destroyed
red blood cells’ membranes. After surface stain-
ing, cells were ﬁxed with 4% paraformaldehyde
(CellFix
®) for 20 min on ice, permeabilized with
1% saponin (PermWash
®), stained with anti-phos-
photyrosine antibody (clone 4G10, Santa Cruz
Biotechnology, USA), that detects all kinds of
phosphotyrosine containing proteins or isotype
control (IgG2b, clone 27–35, Pharmigen) and
analyzed by ﬂow cytometry. The ratio between
mean ﬂuorescence intensity of the stimulated and
unstimulated cells was calculated.
2.8. Statistics
Statistical analysis was performed by Student’s
paired/unpaired t-test or correlation calculations
(Prism 3.0, GraphPad Software Inc., USA). All
data presented are meanS.E.M. ***P0.001,
**P0.01 and *P0.05.
3. Results
In order to determine immunosenescence, the
total number and percentage of lymphocytes were
investigated in freshly collected blood samples.
Several events were determined after mitogenic
activation, e.g. phosphorylation of tyrosine
residues after 3 min, expression of CD69 and
cytokines after 4 and 22 h, respectively and prolif-
eration was assessed after 72 h.
3.1. Absolute number of total T cells, as well as




To determine the absolute amount of T
lymphocytes with respect to their subsets, an
aliquot of heparinized blood samples was
quantiﬁed by ﬂow cytometry using TrueCount
®
beads and antibodies against CD3, CD8 and
CD4. Only CD3-PerCp-positive cells were elec-
tronically gated and a minimum of 100,000 cells
per experiment was acquired. No changes con-
cerning appearance of the forward-side scatter
plot could be observed. In both age groups,
lymphocytes could be clearly identiﬁed and were
sharply determined from monocytes and granulo-
cytes. The number of CD3-positive cells signiﬁ-
cantly decreased in aging (CD3, young:
1888147 cells/l; old: 1236153 cells/l; n=
17–21; P0.005). The loss of cells observed in
aged subjects seemed to be distributed to both
subsets (CD4, young: 1109103 cells/l; old:
76384 cells/l; n=17–21; P0.012 and CD8,
young: 60153 cells/l; old: 35368 cells/l;
n=17–21; P0.005; Fig. 1A). However, it ap-
peared that the number of CD8
+ cells was more
affected by aging (42% less cells per l compared
with young donors) than the T helper
lymphocytes (CD4
+; 32% less cells per l).
In addition, the mean ﬂuorescence intensity
(MFI) that is proportional to receptor surface
density was measured from the above determina-
tions. The density of the CD3- and CD4-receptor
was not altered between the group of young and
old donors (CD3, young: 18217; old: 1607,
CD4, young: 13010; old: 12210; n=11–14;
Fig. 1B). Interestingly, the density of CD8-recep-K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 381
tor on each single CD8
+ T cell was signiﬁcantly
decreased in the aged group (CD8, young: 1300
151; old: 102581; n=11–14; *P0.05; Fig.
1B).
To explore the changes of subsets within the
whole lymphocyte population, the percentage of
T-, B- and NK (natural killer)-lymphocytes were
surveyed and plotted against the donors’ age. The
percentage of CD3-positive cells (within the gated
lymphocyte population, as determined by gating
in FSC/SSC) decreases with age (n=54; **P
0.002; r
2=0.15; Fig. 2A). The ratio of T helper to
T suppressor-lymphocytes, termed CD4/CD8-ra-
tio, was not signiﬁcantly changed in old individu-
als (young: 1.910.18; old: 1.680.21;
n=20–22; Fig. 2B). The very slight insigniﬁcant
reduction of the CD4/CD8-ratio in the aged
group became evident, looking at the absolute
number of CD4
+ and CD8
+ cells. The loss of
CD8
+ cells was more dominant than the loss of
CD4
+ in aging (Fig. 1A). However, when the
CD4/CD8-ratio was correlated with the donor’s
age, there were no statistically signiﬁcant changes
(n=53; r
2=0.004, data not shown). The percent-
age of B lymphocytes was not signiﬁcantly af-
fected by the volunteer’s age (n=53, r
2=0.006;
data not shown). Focussing on the NK subset,
there was a signiﬁcant increase of the percentage
of CD16
+ and CD56
+ cells within the
lymphocyte gate (n=53; ***P0.001; r
2=0.19;
Fig. 2C).
3.2. Tyrosine phosphorylation subsequent to TCR
engagement declines with the donor’s age
After TCR engagement, the number of phos-
phorylated tyrosines raises as a consequence of
the induction of kinase cascades. Whole blood
cultures were stimulated with PHA-L (10 g/ml)
or remained untreated for 3 min at 37 °C with
gentle agitation. Cells were transferred on ice in
order to stop the reactions. Surface and intracellu-
lar staining was performed as described. A ratio
was calculated from the mean ﬂuorescence inten-
sity of PHA-L stimulated and the untreated con-
trol cells.
The ratio of tyrosine phosphorylation of CD4
+
lymphocytes correlated signiﬁcantly with the
donor’s age (***P0.001; n=30; open circles in
Fig. 3), indicating a lower sensitivity of T helper
cells via the TCR in aging. However, no statisti-
cally signiﬁcant correlation was found for the
amount of phosphorylated tyrosine residues with
aging in the CD8 subset (P=0.083; n=30; open
triangles in Fig. 3). A comparison of the two age
groups revealed a highly signiﬁcant reduction of
the phosphorylated tyrosine-ratio in T helper
lymphocytes (CD4, young: 1.4730.065; old:
1.1800.283; ***P0.001; n=13–14; Fig. 3 in-
set). In CD8
+ cells, levels of phosphorylated ty-
rosine were reduced as well, though not
statistically signiﬁcant (CD8, young: 1.319
0.063; old: 1.2090.035; P=0.074; n=13–14;
Fig. 3 inset).
3.3. Expression of early actiation marker CD69
upon PHA-L and PMA/Ionomycin stimulation
decreases with aging
Whole blood cultures were prepared as de-
scribed above and stimulated with 10 g/ml PHA-
Lo r5 0n g /ml PMA and 200 ng/ml Ionomycin.
After 4 h incubation, leukocytes were stained with
CD3-PerCp, CD8-PE and CD69-FITC and fur-
ther processed as indicated. Fig. 4 shows a set of
density plots 4 h without stimulation (control;
Fig. 4, upper panel) and with stimulation (PHA-
L, Fig. 4, middle panel and PMA+Ionomycin,
Fig. 4, lower panel) from one young and one old
individual.
Basal levels of CD69 in untreated control cells
were quite low and not different between young
and old humans (CD4, young: 1.160.22%; old:
1.140.17%; CD8, young: 1.910.52%; old:
1.750.38%; n=19–20). A reduction of CD69
expression after T-cell activation with PHA-L was
determined for both T-cell subsets in the aged
group compared to the young group (CD4,
young: 49.642.64%; old: 39.593.56%; *P
0.014; CD8, young: 53.092.86%; old: 42.28
4.30%; *P0.02; n=19–20; Fig. 5A).
The phorbolester PMA and the calcium
ionophore Ionomycin bypassed the T-cell receptor
by directly activating protein kinase C and by
elevating the intracellular levels of Ca
2+. Levels
of activated cells were signiﬁcantly increased afterK. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 382
Fig. 4. Density plots of CD69 expression at basal condition (upper panel) and after activation with PHA-L (middle panel) and PMA
and Ionomycin (lower panel) for 4 h of a young and an old donor. Only CD3-PerCp-positive gated leukocytes are displayed in the
plot. Left quadrants represent CD8− cells, e.g. CD4
+ lymphocytes, right quadrants show CD8
+ T cells. The upper quadrants show
CD69+ lymphocytes, those in the left are CD4+CD69+ and the quadrants in the right upper quadrant are CD8+CD69+.
PMA and Ionomycin treatment in both subsets
when compared with the corresponding PHA-L
treatment of each group (
+++P0.0001). CD8-
cells derived from young donors showed maximal
CD69 expression (nearly 100%) after PMA and
Ionomycin treatment. Interestingly, CD4-K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 383
lymphocytes were unable to respond to this with
the maximal capacity within 4 h. CD69 expression
decreased highly signiﬁcantly on CD8
+ cells and
signiﬁcantly on CD4
+ lymphocytes in aging
(CD4, young: 85.252.40%; old: 75.843.3%;
*P0.025; CD8, young: 96.940.66%; old:
92.460.91%; ***P0.001; n=19 in each
group; Fig. 5B).
3.4. Cytokine expression is altered in lymphocytes
deried from aged donors
Whole blood cultures were incubated for 22 h
at 37 °C in the absence (basal) or presence of
mitogenic activation (PHA-L or PMA/Iono-
mycin). Before the cells were harvested and
stained (16 h), Brefeldin A was added to the
cultures in order to block the secretion of the
cytokines. Thus, the cytokines were plugged in the
Golgi and could therefore be stained with appro-
priate antibodies (Fig. 8).
The percentages of cytokine expressing cells of
both age groups are summarized in Table 1.
Lymphocytes derived from aged donors (n=9)
showed reduced levels of IL2 and tumor necrosis
factor- (TNF-) expression even basal but as
well upon activation, when compared with young
controls (n=10). In contrast, production of inter-
feron- (IFN-) was signiﬁcantly elevated in
PHA-L activated cells from aged persons.
Basal interleukin-2 (IL2) expression was not al-
tered in lymphocytes from aged volunteers.
Subsequent to stimulation with PHA-L or PMA/
Ionomycin, cells from the elderly tended to dis-
play reduced levels of IL2 expressing cells.
A saT H1 cytokine, IL2 was mainly expressed in
CD4
+ T lymphocytes. In addition, levels
of IFN- were determined. Here, the percentage
of basal IFN- producing lymphocytes was not
altered in lymphocytes from aged donors.
Upon stimulation with PHA, cells from old
donors displayed signiﬁcantly more IFN- posi-
tive cells in both T cells subsets when com-
pared with old controls. Bypassing the TCR with
PMA/Ionomycin revealed the largest amounts of
IFN-. However, changes between the age groups
were not signiﬁcant. Finally, the percentage of
TNF- positive cells was determined. The T
helper subset showed age-related differences in the
basal expression of TNF-. In the CD8
+ popula-
tion, those changes were not that evident. Mito-
genic activation of the cells tends to effect
age-related changes more in the CD8 than in the
CD4 subset.
Fig. 5. Expression of the early activation marker CD69 is
reduced in aging. Whole blood cultures were activated with
either PHA-L or PMA/Ionomycin for 4 h at 37 °C. Subse-
quently, cells were surface stained for CD3, CD8 and CD69.
Only CD3 positive gated cells were analyzed for CD69 expres-
sion. (A) TCR engagement triggered by PHA treatment re-
vealed signiﬁcantly reduced levels of CD69 expressing cells in
aged donors in both T cell subsets. (B) This pattern remained
when the TCR complex was bypassed with PMA/Ionomycin,
though the age-related differences were smaller. (n=19 per
group, *P0.05; ***P0.001 compared to young controls;
+++P0.001 compared to the corresponding PHA-L stimu-
lation in CD4 and CD8 cells of young individuals; §§§P0.001
compared to the corresponding PHA-L stimulation in CD4
and CD8 cells of old individuals).K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 384
Fig. 6. Dot plots of BrdU-incorporation upon stimulation with PHA-L taken from a young and old subject. Cells were stained with
an isotype antibody as control or with an antibody raised against BrdU to explore the content of proliferating cells. Only
CD3-PercP-positive gated leukocytes are displayed in the dot plot. Left quadrants represent CD8− cells, e.g. CD4+ lymphocytes,
right quadrants show CD8+ T cells. The upper quadrants show BrdU+ lymphocytes, those on the left are CD4+BrdU+ and those
in the right upper quadrant are CD8+BrdU+. After 72 h PHA-L activation, the T lymphocytes from the young individual clearly
shows more cells that are positive for anti-BrdU staining than the T cells from the old person.
3.5. Lymphocyte proliferation is signiﬁcantly
reduced in aging
Seventy-two hours after preparation of the
whole blood cultures and mitogenic stimulation,
leukocytes were stained as indicated. Preliminary
experiments showed that stimulation for 3 days
and BrdU-pulse for 24 h are optimal conditions
for our purpose. Fig. 6 shows density plots from
one young and one old individual after PHA-L
stimulation (10 g/ml).
When proliferation was induced by activation
with PHA-L via TCR ligation, T cells derived
from young donors incorporated signiﬁcantly
more BrdU within 24 h than cells from elderly
persons, indicating a higher proliferation (CD4,
young: 24.751.98%; old: 16.071.92%; **P
0.005; CD8, young: 42.213.81%; old: 19.86
1.76%; ***P0.0001; n=22–25; Fig. 7A). When
the percentage of BrdU
+ cells was plotted against
increasing age, there was signiﬁcant negative cor-
relation (CD4, **P0.002; CD8, ***P0.0001).
By circumventing the TCR complex with PMA
and Ionomycin, the signiﬁcant decrease of BrdU-
positive cells in aging was still evident (CD4,
young: 33.432.84%; old: 24.352.99%; *P
0.023; CD8, young: 50.705.05%; old: 27.85
2.86%; ***P0.001; n=22–25; Fig. 7B). Levels
of proliferating lymphocytes from aged donors
were signiﬁcantly increased after PMA and Iono-
mycin treatment in both subsets when compared
with the corresponding PHA-L treatment of each
group (
§P0.05). In cells derived from young
volunteers, only CD4




Correlation with age revealed only in CD4
+
lymphocytes a signiﬁcant correlation with age
(*P0.05). It is noteworthy that in young cells
the proliferative activity of the T lymphocytes was
mainly triggered by the CD8 subsets.
4. Discussion
The decline of immune function with aging has
been a subject in various studies, reviews and
comments. However, most studies focus on only
one event after mitogenic activation. To our
knowledge, there is no study determining several
chronological aspects of lymphocyte activation in
aging with respect to subsets. In addition, we
carried out the lymphocyte experiments in wholeK. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 385
blood cultures in order to maintain their physio-
logical environment and to avoid cellular activa-
tion or cell death due to isolation procedure.
Moreover, endocrine factors and cytokines, which
have a great inﬂuence on immunosenescence, re-
mained in the culture vessel and were not washed
out during isolation. Lymphocyte activation with
lectin (PHA-L) is believed to be quite similar to
that taking place in the organism.
Fig. 8. Plots of cells intracellularly stained for IFN- after
stimulation with PHA for 22 h. Secretion of cytokines was
blocked by Brefeldin A treatment for 16 h. Only CD3-PercP-
positive gated leukocytes are displayed in the dot plot. Left
quadrants represent CD8− cells, e.g. mainly CD4
+
lymphocytes, right quadrants show CD8
+ T cells. The upper
quadrants show IFN-
+ lymphocytes, those in the left are
CD8− IFN-+ and those in the right upper quadrant are
CD8+.
Fig. 7. Proliferation according to activation decreases in the
lymphocytes of young and aged donors. (A) PHA-L stimu-
lated cells show a markedly increased proliferation in the CD8
subset compared to CD4 positive lymphocytes. In aging, the
number of BrdU-incorporating cells is signiﬁcantly reduced in
both subsets. (B) Activation subsequent to PMA/Ionomycin
treatment showed, in addition, a higher percentage of prolifer-
ating cells within the CD8 subset. Moreover, lymphocytes
from young donors revealed signiﬁcantly elevated levels of
BrdU positive cells when compared with old controls (n=22–
25, *P0.05; **P0.01; ***P0.001 compared to young
controls; +P0.05 compared to the corresponding PHA-L
stimulation in CD4 and CD8 cells of young individuals;
§P0.05 compared to the corresponding PHA-L stimulation
in CD4 and CD8 cells of old individuals).
TCR engagement, that was mimicked in this
study by the lectin PHA-L, resulted in phosphory-
lation of tyrosine-residues mediated by Src and
Zap-70-family members (Weiss and Littman,
1994), followed by activation of Ras and Raf/
MAP kinase cascade and PLC- (phospholipase-
), which interacted with PKC (protein kinase C).
Gene expression was induced by the rapid inacti-
vation of IB- and subsequent nuclear migration
of active NF-B dimers (Kuo and Leiden, 1999).
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ization of Fos and Jun that formed the transcrip-
tion factor AP-1. In addition, IP3 concentration
was raised due to PLC activity and proceeded to
release Ca
2+ from intracellular stores. Elevated
Ca
2+ levels initiated the phosphatase calcineurin,
which dephosphorylated the transcription factor
NF-AT, thereby becoming active. Treatment of
lymphocytes with phorbol ester (PMA) plus Iono-
mycin bypassed the TCR engagement by direct
interaction of the PMA with PKC and by increas-
ing the intracellular Ca
2+ levels due to ionophore
Ionomycin. Altered T cell functionality due to
impaired TCR function and/or decreased TCR-
complex expression should be avoided by PMA
plus Ionomycin regimen.
We observed a signiﬁcantly decreased number
of total T lymphocytes in CD3 and in the CD4
and CD8 subsets in aged humans. However, the
CD4/CD8-ratio remained unchanged with aging.
In an earlier study, we found increased basal
apoptosis of lymphocytes derived from aged indi-
viduals (Schindowski et al., 2000). The enhanced
incidence of apoptosis might be associated with
the loss of CD3
+ cells. A lack of T cells may be
one of the numerous causes of immunosenes-
cence, since fewer cells providing immune func-
tion are available to maintain immune
homeostasis. In agreement with our ﬁndings, a
dramatic decrease of lymphocyte count have been
observed during the last 3 years before death in a
prospective study (Bender et al., 1986).
Soluble CD8 receptor is a marker for T sup-
pressor cell activation (Lenkei et al., 1998). Re-
duced density of CD8 receptor on T suppressor
cells from the elderly could be related to increased
levels of soluble CD8. However, Ginaldi et al.
(2001) present no changes in the density of CD8
antigen, but it should be noted that they were
investigating a subgroup of T cells (CD3
+CD7
−)
while here, we determined all CD3
+. Interest-
ingly, in neurological disorders like DAT, in-
creased levels of soluble CD8 are involved as well
(Singh, 1994).
Due to thymic involution, however, the number
of untouched CD4 and CD8-cells declines with
increasing age and with the number of infections
during life. Unprimed cells carry the CD45RA
isoform of the CD45-receptor, while memory cells
express the CD45R0 epitope (Vitetta et al., 1991).
We and others (O’Leary et al., 1988; Yen et al.,
2000) found no signiﬁcant changes of the CD4/
CD8 ratio with aging. This is an interesting fact
as some neurological disorders (DAT and MS, for
instance) show increased CD4/CD8-ratios (Shalit
et al., 1995; Crucian et al., 1995b; Schindowski et
al., 1999).
Table 1
Altered cytokine production in aging
CD4 CD8
Basal PMA/Ionomycin PMA/Ionomycin PHA-L Basal PHA-L
1.430.88 15.677.21 Young IL-2 4.953.29 0.300.20 30.804.51 11.485.95
Old 1.290.64 5.171.36 22.744.33 0.410.35 0.510.90 10.135.72
1.400.90 3.561.24 16.384.25 IFN- Young 0.700.34 0.890.35 6.501.35
11.915.31 Old 0.470.33 8.761.30** 19.793.04 0.250.12 2.210.35**
38.8812.20 8.053.10 3.801.91 31.916.49 TNF- 4.271.68 3.221.76 Young
5.523.01 25.5014.21 1.150.71 4.171.52 19.427.86 Old 0.140.07*
* P0.05 compared to young controls.
** P0.01 compared to young controls.
IL2, IFN- and TNF- cytokine expression in lymphocytes from young and old donors. Data is expressed in percent of cytokine
expressing cells (meansS.E.M.). Whole blood cultures were stimulated either with PHA-L or PMA/Ionomycin as described or
remained untreated (basal) for 22 h. Brefeldin A was added 16 h prior to harvesting the cells. Leukocytes were surface-stained for
CD3 and CD8, ﬁxed and permeabilized. Staining with ﬂuorochrome-coupled antibodies against IL2, IFN-, TNF- or isotype-con-
trol identiﬁed cytokine expressing cells.K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 387
Mitogenic activation of T cells leads to the
phosphorylation and activation of p56
lck kinase.
p56
lck associates with CD4 and CD8 costimula-
tory receptor molecules (Abraham et al., 1991).
Here, we could show that tyrosine phosphoryla-
tion was age-related decreased in CD4
+ cells.
CD8
+ lymphocytes display insigniﬁcantly reduced
phosphorylation ratios. Recently, an altered asso-
ciation of p56
lck with coreceptors such as CD4
was found in the elderly (Tinkle et al., 1998),
suggesting that alterations in p56
lck tyrosine ki-
nase and its association with CD4 may underlie
lowered T cell function during aging.
Moreover, in earlier studies we could show
lowered Ca
2+ mobilization after mitogenic stimu-
lation with PHA-L in lymphocytes derived from
aged individuals (Eckert et al., 1997, 1998).
CD69 was formerly known as activation in-
ducer molecule (AIM) and is a 60-kDa glycosy-
lated costimulatory molecule for T lymphocyte
proliferation, which is expressed after ligation of
CD3/T cell receptor complex (Hamann et al.,
1998). Although the physiological role of CD69 is
still unknown, crosslinking of CD69 induces pro-
liferation. Expression of CD69 in T cells is depen-
dent on the appropriate activation of several
intracellular signaling pathways including IP3 pro-
duction, increases in intracellular Ca
2+ and the
activation of Ras/Raf-1/MAP kinase pathway
(Perfetto et al., 1997). In concordance with
Rutella et al. (1999), we could show that CD8
+
cells display more CD69-expression after PHA-L




lymphocytes derived from elderly persons had
reduced CD69 surface expression compared to
young persons. After treatment with phorbol ester
and Ca
2+ ionophore, the expressed amount of
CD69 was signiﬁcantly higher than after TCR
engagement in both age groups. Moreover, a sig-
niﬁcant age-related difference in expression of
CD69 was evident when bypassing the TCR com-
plex with PMA and Ionomycin. These data indi-
cate that impaired expression of the activation
marker CD69 in aging by engagement and even
by bypassing the TCR. However, reduced activa-
tion of lymphocytes from elderly humans seems,
therefore, not only to be due to lower expression
of CD3 and/or followed by reduced signal trans-
duction (Fulop et al., 1995) after TCR ligation,
but also age-related diminished transcription
might be involved in our ﬁndings (Whisler et al.,
1996).
Many earlier reports using different techniques
to determine serum levels of cytokines indicate
that the lymphocyte’s response to mitogens is
impaired in elderly subjects (Murasko et al., 1986;
Nagel et al., 1988; Bruunsgaard et al., 2000a). In
this study, we could only detect a tendency of
lymphocytes from young donors to produce more
IL-2. However, due to large S.E.M. we could not
show signiﬁcant age-related differences with this
method. The relevance of decreased production of
IL2 (Rabinowich et al., 1985; Barcellini et al.,
1988) in aging, the major growth factor for T
cells, remains unclear. However, a prior study
revealed no changes in CD25 (-chain of the IL2
receptor) expression with aging (Schindowski et
al., 2000). The role of interferons in aging is not
yet clear. Decreased levels of interferons (IFN-
and - (Miller, 1980; Lio et al., 2000)) were found
by some laboratories while other investigators
determined increased levels (Fahey et al., 2000;
Sakata-Kaneko et al., 2000; Yen et al., 2000). In
addition, our data are in concordance with the
latter showing that activated T cells of both sub-
sets from elderly individuals produced more IFN-
 than from young controls. The serum
concentration of the inﬂammatory cytokine TNF-
 increases with aging (Bruunsgaard et al.,
2000b). However, it remains to be elucidated
which cells secrete more TNF- in the elderly. An
increased activity of monocytes and macrophages
(Han et al., 1995; Sadeghi et al., 1999) or NK cells
(Solana and Mariani, 2000), observed in aged
individuals, could be responsible for elevated lev-
els of TNF- as well. Moreover, in neurological
disorders that are related to neuroinﬂammation
and increased activity of glial cells, elevated levels
of TNF- and IL6 are detected as in DAT (Singh,
1994) and in parkinsonism (Dobbs et al., 1999).
A decreased amount of transcription factors
(AP-1, NFB and NFAT) have been observed in
aged individuals (Trebilcock and Ponnappan,
1996), resulting in fewer transcription of genes
after mitogenic activation. Since not only protein
levels but mRNA levels of IL2 as well are de-K. Schindowski et al. / Mechanisms of Ageing and Deelopment 123 (2002) 375–390 388
creased in aging (Barcellini et al., 1988; Nagel
et al., 1988), reduced activation of transcrip-
tion factors surely is another aspect in immuno-
senescence.
Decline of immune function with increasing age
is not restricted to T lymphocytes: several groups
reported impaired B cells function (Hijmans et al.,
1984; Antonaci et al., 1985; Paganelli et al., 1992;
Burns et al., 1993). However, we could show that
aging affects CD4
+ cells that interact with B
lymphocytes. A defective T helper activity might
contribute to an altered B cell functionality and
could account for one aspect of the altered hu-
moral activity associated with aging (Guidi et al.,
1998). Natural killer lymphocytes are supposed to
be involved in immunosurveillance against tumors
and in viral defense. Their age-related changes in
activity are still controversially discussed through
literature (Murasko et al., 1986), but most studies
show increased activation of NK cells with ad-
vancing age. In the present study, a signiﬁcant
correlation with donor’s age of the percentage of
NK cells within the lymphocyte population was
determined.
Depressive illness and affective disorders are
associated with immune and cytokine alterations
(Irwin et al., 1987; Zaharia et al., 1993). Reduc-
tions of lymphocyte response to PHA and in vitro
IL2 production are effects of repeated stress in
rats (Batuman et al., 1990). The neurodegenera-
tive disorder itself has proven effects on central
and peripheral immune competent cells as well
(Garibaldi and Zhang, 1999; Eckert et al., 2001).
Recently, we could show that the CD4/CD8-ratio
of Alzheimer’s disease patients signiﬁcantly corre-
lates with the disease’s severity (measured as cog-
nitive decline). Since there is no change of the
ratio of T helper to T suppressor cells associated
with aging, the impact of the pathological increase
of CD4
+ cells and the decrease of CD8
+ cells
seen in DAT should be further explored.
In conclusion, the age-related modiﬁcations of
human peripheral lymphocytes are important in
order to elucidate additional changes taking place
in neurological diseases of geronto-psychiatric
patients.
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